To the Editor:
We read with great interest the report "Interference of Radio-opaque Agents in Clinical Capillary Zone Electrophoresis" (1 ) . A laboratory sent two similar patient samples for our evaluation. Both patients had received intravenous sodium meglumine ioxitalamate (Telebrix), a radioopaque contrast material that absorbs at 214 nm. The interfering substance was not visible on agarose gels (Paragon ® SPE), whereas the capillary zone electrophoresis (CZE) results (Paragon CZE ® 2000) showed a peak in the alpha-2 zone, which may be mistaken for a monoclonal protein (see Fig. 1A ). The anomalous peak was not removed by reaction with antisera to any of the immunoglobulins.
The samples were then desalted (D-Salt Dextran plastic desalting columns, 5-kDa cutoff; Pierce). Several similar products are available. After capillary electrophoresis, the desalted samples (see Fig. 1B ) appeared normal with the questionable peak entirely removed, thus confirming that the interfering substance was of low molecular weight and, therefore, not a paraprotein. The desalting procedure was fast and simple. Clinical laboratories that use CZE could easily use this method to evaluate questionable samples. 
Comment on the Overestimation of Methemoglobin Concentrations in Neonatal Samples with the Chiron 800 System CO-Oximeter Module

To the Editor:
We wish to comment on the Technical Brief of Lynch et al. (1 ) , who reported overestimation of methemoglobin concentrations in neonatal samples containing fetal hemoglobin and analyzed with the Chiron 800 system CO-oximeter. Overestimation of methemoglobin in the presence of fetal hemoglobin may have serious implications, with the possibility of premature termination of nitric oxide treatment. In our hospital, Ͼ1000 methemoglobin analyses are performed annually on request of our neonatal intensive care unit. These measurements have been performed with a CIBA Corning 270 CO-oximeter and, at present, are also performed with a Chiron 865 blood gas analyzer equipped with a COoximetry module (Chiron Diagnostics NV).
We decided to investigate this alarming report and used both analyzers to measure methemoglobin concentrations in three sets of samples. The first set consisted of 10 samples from our neonatology department. In these samples, the concentration of fetal hemoglobin was 65% or higher. The second and third sets of samples consisted of adult blood and umbilical cord blood, respectively, collected in heparin-containing tubes and divided into two portions. In one portion of each sample, 100% methemoglobin was obtained by adding potassium nitrite 
